Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a NSAID presented as an oral tablet for oral use. It is used to relieve pain and inflammation associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain conditions.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable global distribution.

Movalis, a non‑steroidal anti‑inflammatory drug, is indicated for inflammatory joint diseases and short‑term pain relief. - Osteoarthritis: reduces joint pain and swelling, improving function. - Rheumatoid arthritis: alleviates chronic inflammation and joint damage progression. - Ankylosing spondylitis: diminishes spinal pain and stiffness. - Acute pain: provides rapid relief of moderate to severe pain episodes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort, such as dyspepsia or nausea. - Headache. - Dizziness. - Peripheral edema. - Mild skin rash.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Cardiovascular events, including myocardial infarction. - Elevated liver enzymes indicating hepatic injury. - Severe skin reactions, such as Stevens‑Johnson syndrome. - Acute kidney injury or worsening of renal function.

Before prescribing Movalis, clinicians should evaluate patient‑specific risk factors. - Cardiovascular risk: assess history of heart disease before use. - Gastrointestinal risk: avoid in patients with active ulcers or severe GI disorders. - Renal function: monitor kidney parameters in patients with impairment. - Hepatic function: check liver enzymes periodically. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Meloxicam may alter the effect of several co‑administered medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance nephrotoxic potential. - Lithium: NSAIDs can raise lithium serum levels, requiring monitoring.